Pure Global
NCT04610216

Investigation of the Automatic Technology on the Naída M Hearing Devices

Advanced Bionics AG·ClinicalTrials.gov·device·Device trialRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Cochlear Hearing Loss
Drug/Device/Intervention
Naida CI M hearing device
Study type
Observational
Intervention type
device
Sponsor & location
Primary sponsor
Advanced Bionics AG
Location
Geneva, Switzerland
Timeline & enrollment
Phase
N/A
Start date
Oct 20, 2020
End date
Oct 31, 2021
Enrollment
15 participants
Primary outcome

Difference in speech intelligibility in noise

Summary

In this clinical trial, an un-controlled, repeated measures open design with within-subject
 comparison will be used to evaluate the effect of the device under investigation on sound
 perception. This design was shown to be successful in previous studies for the evaluation of
 sound coding strategies.
 
 Furthermore, a within-subject comparison decreases the variance in the results allowing for
 fewer subjects when the population using the investigational device is not large in general.

ICD-10 classifications
Other hearing lossOther specified hearing lossOtotoxic hearing lossHearing loss, unspecifiedSudden idiopathic hearing loss
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT04610216
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT04610216 through Pure Global AI's free database. This phase not specified trial is sponsored by Advanced Bionics AG and is currently Recruiting. The study focuses on Cochlear Hearing Loss. Target enrollment is 15 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.